| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
Fatostatin hydrobromide-Fatostatin A hydrobromide | 125B11 hydrobromide
|
298197-04-3 |
FATOSTATIN
|
|
C18H18N2S.HBr |
375.328 | |
|
STF 083010
|
307543-71-1 |
STF 831
|
STF 083010;(E)-N-((2-hydroxynaphthalen-1-yl)methylene)thiophene-2-sulfonamide;N-[(2-Hydroxy-1-naphthalenyl)methylene]-2-thiophenesulfonamide
|
|||
|
Cyclosporin G
|
74436-00-3 |
吉环孢素
|
环孢素杂质7;环孢素杂质G;环孢菌素G;CS-2593;环孢菌素杂质G;吉环孢素
|
C63H113N11O12 |
1216.65 | |
|
Peficitinib
|
944118-01-8 |
PEFICITINIB
|
ASP015K;JNJ-54781532;CS-2584;ASP015K;JNJ-54781532;ASP-015K;ASP 015K;JNJ54781532;JNJ 54781532
|
C18H22N4O2 |
326.39288 | |
|
PF 05175157
|
1301214-47-0 |
PF5175157
|
|
C23H27N5O2 |
||
|
PI-1840
|
1401223-22-0 |
PI-184
|
PI-1840;N-isopropyl-2-(4-propylphenoxy)-N-((3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl)methyl)acetamide;N-(1-methylethyl)-2-(4-propylphenoxy)-N-[[3-(3-pyridinyl)-1,2,4-oxadiazol-5-yl]methyl]-acetamide
|
|||
|
JTE-013
|
383150-41-2 |
JTE-13
|
1-(2,6-dichloropyridin-4-yl)-3-[(1,3-dimethyl-4-propan-2-ylpyrazolo[3,4-b]pyridin-6-yl)amino]urea;N-(2,6-Dichloro-4-pyridinyl)-2-[1,3-dimethyl-4-(1-methylethyl)-1H-pyrazolo[3,4-b]pyridin-6-yl]hydrazinecarboxamide;1-[1,3-Dimethyl-4-(2-methylethyl)-1H-pyrazolo[3,4-b]pyridin-6-yl]-4-(3,5-dichloro-4-pyridinyl)-semicarbazide;1-[1,3-Dimethyl-4-(2-methylethyl)-1H-pyrazolo[3,4-b]pyridin-6-yl]-4-(2,6-dichloro-4-pyridinyl)-semicarbazide;1-(2,6-dichloro-4-pyridyl)-3-[(4-isopropyl-1,3-dimethyl-pyrazolo[3,4-b]pyridin-6-yl)amino]urea
|
|||
|
SGC2085
|
1821908-48-8 |
CS-2529
|
SGC-2085;SGC 2085;CS-2529;CS-2688
|
C19H24N2O2 |
||
|
Dihydrocyclosporin A
|
59865-15-5 |
二氢环孢菌素A
|
环孢素杂质10;CS-2523;二氢环孢菌素A;双氢环孢菌素A;环孢素A二氢杂质;二氢环孢素 A;二氢环孢菌素杂质A
|
C62H113N11O12 |
1204.63 | |
|
CCT245737
|
1489389-18-5 |
CCT245737
|
|
C16H16F3N7O |
379.33975 | |
|
PD166866
|
192705-79-6 |
PD-166866
|
PD-166866;PD 166866;CS-2496
|
C20H24N6O3 |
396.44296 | |
|
GSK'872
|
1346546-69-7 |
GSK872
|
|
C19H17N3O2S2 |
383.48718 | |
|
Vadadustat
|
1000025-07-9 |
Vadadustat
|
N-(5-(3-氯苯基)-3-羟基吡啶-2-羰基)甘氨酸;PG-1016548;AKB-6548;维达司他;瓦斯塔特
|
C14H11ClN2O4 |
306.70114 | |
|
S-63845
|
1799633-27-4 |
S63845
|
苯丙酸,α-[[(5S)-5-[3-氯-2-甲基-4-[2-(4-甲基-1-哌嗪基)乙氧基]苯基]-6-(5-氟-2-呋喃基)噻吩[2,3-d]嘧啶-4-基]氧基]-2-[[1-(2,2,2-三氟乙基)-1H-吡唑-5-基]甲氧基],(αR)-
|
C39H37ClF4N6O6S |
829.2592928 | |
|
(S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)ethan-1-amine
|
1703793-34-3 |
CPD1212
|
BLU-285
|
C26H27FN10 |
498.5579832 | |
|
OXAMFLATIN
|
151720-43-3 |
OXAMFLATIN
|
CS-2473;METACEPT 3;OXAMFLATIN;(2E)-N-羟基-5-[3-[(苯磺酰基)氨基]苯基]-2-戊烯-4-炔酰胺
|
C17H14N2O4S |
342.36906 | |
|
AF 353
|
865305-30-2 |
AF 353
|
5-(5-碘-2-异丙基-4-甲氧基苯氧基)嘧啶-2,4-二胺;5-[5-碘-4-甲氧基-2-(1-甲基乙基)苯氧基]-2,4-嘧啶二胺;CHEMBL526307;AF 353;AF353;CS-2469
|
C14H17IN4O2 |
400.21485 | |
|
JNJ 16259685
|
409345-29-5 |
CS-2455
|
3,4-二氢-2H-吡喃并[2,3-B]喹啉-7-基(4-甲氧基环己基(甲酮;CS-2455
|
C20H23NO3 |
325.40152 | |
|
Refametinib
|
923032-37-5 |
REFAMETINIB
|
BAY 869766;BAY 86-97661;RDEA119;瑞法替尼;BAY 869766;BAY 86-9766;CS-2434;瑞法替尼;瑞美替尼
|
C19H20F3IN2O5S |
572.33718 | |
|
CGS 21680 Hydrochloride
|
124431-80-7 |
CGS2168HCL
|
|
C23H30ClN7O6 |
535.9806 |
药智官方微信
药智官方微博
